Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01564667 · ClinicalTrials.gov registry record · NA
Attention Bias Modification Treatment for Warzone-Related Posttraumatic Stress Disorder (PTSD)
A NA study, sponsored by Creighton University.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT01564667 is a NA study that has completed, run by Creighton University. The registered enrollment target is 51 participants.
The verdict
NCT01564667, a NA study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
Veterans with Posttraumatic Stress Disorder (PTSD) will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to reduce bias toward threat or a placebo control condition not designed to change attention patterns. Outcome measures will be PTSD, anxiety, depression, and alexithymia symptoms as measured by standard psychological interviews and questionnaires. Participants will also be invited to participate in physiological testing before and after receiving AMBT or placebo to serve as additional outcome measures and assess brain functioning, heart rate, and muscle tension. The investigators expect to see significant PTSD symptom reduction in the Attention Bias Modification Treatment (ABMT) group relative to the placebo control group in which no symptomatic relief is expected. At the end of the study, if ABMT is shown to be effective, we will offer active ABMT to those participants randomly assigned to the placebo arm if they would like to receive the treatment.
Interventions
- BEHAVIORAL Attention Bias Modification Training Protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01564667
The ClinicalTrials.gov registry entry for NCT01564667 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Creighton University, which has 98 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Attention Bias Modification Training Protocol is the first listed.
NCT01564667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01564667 about?
NCT01564667 is a clinical study titled "Attention Bias Modification Treatment for Warzone-Related Posttraumatic Stress Disorder (PTSD)". Veterans with Posttraumatic Stress Disorder (PTSD) will be randomly assigned to either Attention Bias Modification Treatment (ABMT) designed to reduce bias toward threat or a placebo control condition not designed to change attention patterns. Outcome measures will be PTSD, anxiety, depression, and ...
What is the current status of trial NCT01564667?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2012-04. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01564667?
The interventions under investigation include: Attention Bias Modification Training Protocol (BEHAVIORAL).
Who is sponsoring clinical trial NCT01564667?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.